Transgene Biotek - Quarterly Results
14th Feb 2019

Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended December 2018, as compared to corresponding quarter of last year.The Net Loss for the quarter ended December 2018 is Rs. -9.26 millions as compared to Net Loss of Rs. -5.43 millions of corresponding quarter ended December 2017 Operating profit Margin for the quarter ended December 2018 improved to -1.64% as compared to -0.16% of corresponding quarter ended December 2017



(Rs. in Million)


  Quarter ended Year to Date Year ended
  201812 201712 % Var 201812 201712 % Var 201803 201703 % Var
Sales 0.00 1.21 0.00 0.71 1.21 -41.32 1.18 2.81 -58.01
Other Income 0.44 0.44 0.00 1.32 1.37 -3.65 73.73 6.58 1020.52
PBIDT -1.64 -0.16 925.00 -2.56 -2.53 1.19 52.67 -19.04 -376.63
Interest 0.63 0.69 -8.70 1.88 8.88 -78.83 10.28 4.30 139.07
PBDT 15.47 19.31 -19.89 13.30 8.77 51.65 42.39 -23.34 -281.62
Depreciation 24.73 24.74 -0.04 74.18 74.22 -0.05 98.91 175.27 -43.57
PBT -9.26 -5.43 70.53 -60.88 -65.45 -6.98 -56.52 -198.61 -71.54
TAX 0.00 0.00 0.00 0.00 0.00 0.00 7.86 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -9.26 -5.43 70.53 -60.88 -65.45 -6.98 -64.38 -198.61 -67.58
Equity 757.70 757.70 0.00 757.70 757.70 0.00 757.70 757.70 0.00
PBIDTM(%) 0.00 -13.22 -100.00 -360.56 -209.09 72.44 4463.56 -677.58 -758.75